Drug Shortage Report for UROCIT-K
Report ID | 174717 |
Drug Identification Number | 02353997 |
Brand name | UROCIT-K |
Common or Proper name | Potassium Citrate Extended Release Tablets |
Company Name | MISSION PHARMACAL COMPANY |
Market Status | MARKETED |
Active Ingredient(s) | POTASSIUM CITRATE |
Strength(s) | 1080MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 100-ct |
ATC code | A12BA |
ATC description | POTASSIUM |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2022-11-15 |
Estimated end date | Unknown |
Actual end date | 2022-12-05 |
Shortage status | Resolved |
Updated date | 2023-10-03 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 10999 IH 10 WEST SAN ANTONIO, TEXAS UNITED STATES 78230-1355 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2023-10-03 | French | Compare |
v4 | 2023-10-03 | English | Compare |
v3 | 2022-11-16 | English | Compare |
v2 | 2022-11-15 | French | Compare |
v1 | 2022-11-15 | English | Compare |
Showing 1 to 5 of 5